Literature DB >> 12885995

The pulmonary physician in critical care * Illustrative case 6: Acute chest syndrome of sickle cell anaemia.

V Mak1, S C Davies.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12885995      PMCID： PMC1746766          DOI： 10.1136/thorax.58.8.726

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  29 in total

Review 1.  The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

Authors:  J Cranshaw; M J D Griffiths; T W Evans
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

2.  Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin.

Authors:  V M INGRAM
Journal:  Nature       Date:  1957-08-17       Impact factor: 49.962

Review 3.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

4.  Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent.

Authors:  K J Sullivan; S R Goodwin; J Evangelist; R D Moore; P Mehta
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

Review 5.  Transfusion management of sickle cell disease.

Authors:  A S Wayne; S V Kevy; D G Nathan
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

6.  Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease.

Authors:  L A Styles; A J Aarsman; E P Vichinsky; F A Kuypers
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

7.  Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.

Authors:  G P Rodgers; G J Dover; C T Noguchi; A N Schechter; A W Nienhuis
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

8.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

9.  Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells.

Authors:  N C Adragna; P Fonseca; P K Lauf
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

10.  Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.

Authors:  O S Platt; S H Orkin; G Dover; G P Beardsley; B Miller; D G Nathan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808
View more
  2 in total

1.  A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy.

Authors:  D R Leff; T Kaura; T Agarwal; S C Davies; J Howard; A C Chang
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 3.453

2.  Blood transfusion in patients with sickle cell disease requiring laparoscopic cholecystectomy.

Authors:  Amr Mostafa Aziz; Abdul-Wahed N Meshikhes
Journal:  JSLS       Date:  2011 Oct-Dec       Impact factor: 2.172
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.